Navigation Links
PARI in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

...tion. "We are pleased that researchers chose pari products as the exclusive nebulizer systems for re...ambridge, RRT, director of clinical development at pari Respiratory Equipment. The Sutherland et al. ...otropium compared to placebo/tiotropium. The pari LC Plus nebulizer and...

Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

...e information, visit www.cff.org . About pari Pharma and the eFlow (R) Nebulizer System ...elivered by an eFlow Nebulizer System developed by pari Pharma GmbH. The eFlow Nebulizer System uses eFlow...zer System and eFlow Technology are proprietary to pari Pharma and can be optimized to specific drug formu...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

...tures positive Phase Ib clinical trial results for pari Pharma's L-CsA, inhaled liposomal cyclosporine A. In May, pari Pharma received Orphan Drug Designation from the F...ive vice president and chief scientific officer of pari Pharma GmbH. "We had a very encouraging pre-IND m...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

...ciety (ATS) International Conference that compared pari Pharma's inhaled IsoCrom, an isotonic 1% disodium ... by in-vitro study results previously published by pari Pharma and other studies demonstrating that chymas...scientific officer and executive vice president of pari Pharma. At ATS,...

Mpex Initiates a Phase 2 Clinical Trial of Aerosol MP-376 in the Treatment of Chronic Bacterial Infections in Cystic Fibrosis Patients

...)) and other inhaled antimicrobial agents. About pari Pharma and the eFlow(R) Electronic Nebulizer MP-...e, the eFlow(R) Electronic Nebulizer, developed by pari Pharma GmbH. eFlow(R) is a quiet portable nebulize... on PARI's 100-year history working with aerosols, pari Pharma is dedicated to advancing inhalation therap...

Transave Announces Positive Phase II Results for Once-Daily Arikace(TM) in the Treatment of Cystic Fibrosis Patients Who Have Pseudomonas Lung Infections

...seudomonas infections in patients with CF. About pari Pharma and the eFlow(R) Electronic Nebulizer Ari...e, the eFlow(R) Electronic Nebulizer, developed by pari Pharma GmbH. eFlow is a quiet, portable nebulizer ... on its 100-year history of working with aerosols, pari Pharma is dedicated to advancing inhalation therap...

Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results

...isa Cambridge, director of Clinical Development at pari Respiratory Equipment. The trial demonstrated st...e by the European Medicines Agency (EMEA). About pari Respiratory Equipment, Inc. pari is a leading worldwide developer and manufacturer ...

PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study

...REY, Calif., April 17 /PRNewswire/ -- An optimized pari eFlow platform nebulizer will be delivering Alnyla...burden of taking daily inhaled treatments. About pari Pharma pari Pharma develops aerosol delivery devices and inhal...

PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial

...ial for a potential new cystic fibrosis treatment. pari reusable nebulizers are considered the gold standa...ense that so many pharmaceutical companies look to pari when developing new medications," said Lisa Cambridge, director of Clinical Development at pari Respiratory Equipment. "Our LC STAR is a fine part...

PARI's eFlow Included in Gilead's NDA Submission for Aztreonam Lysine for Inhalation

... MONTEREY, Calif., Nov. 26 /PRNewswire/ -- pari Pharma's eFlow electronic nebulizer was included i...halation therapies can average 20 to 25 minutes. pari Pharma GmbH, the developer of the eFlow, also cont...ns in North America, Europe and Australia. About pari Pharma ...

Gilead Announces Presentation of Positive Phase III Data on Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

...ug status in the United States and Europe. About pari and the eFlow Electronic Nebulizer Aztreonam lys...vice, the eFlow Electronic Nebulizer, developed by pari Pharma GmbH. The eFlow is an electronic, portable ...edications via a vibrating, perforated membrane. pari is dedicated to advancing aerosol therapies throug...

Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis

...ched placebo administered three times daily by the pari eFlow(R) Electronic Nebulizer. Aztreonam lysine-tr...signation in the United States and Europe. About pari Pharma and the eFlow Electronic Nebulizer Aztreo... medications via a vibrating, perforated membrane. pari Pharma also contributed to the development and opt...

PARI and Kamada Announce Positive Intermediate Phase I Results for Inhaled Alpha-1 Antitrypsin

...he long term," said Dr. Martin Knoch, President of pari Pharma GmbH. "By developing a targeted therapy tha...://www.kamada.com/">http://www.kamada.com About pari Pharma pari Pharma focuses on the development of aerosol deliv...

PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference

... MUNICH, Germany, June 14, 2007 /PRNewswire/ -- pari Pharma will present in-vivo study results for their pari SINUS pulsating drug delivery system as well as lu...ing highly advanced inhalation delivery platforms, pari has created a pulsating sinus drug delivery system...
Other Tags
(Date:4/20/2014)... Most drugs used to treat lung, breast and pancreatic ... Researchers at the University of California, San Diego School ... CD61 on the surface of drug-resistant tumors that appears ... cell-like properties of cancer cells. , The findings, ... Nature Cell Biology , may point to new ...
(Date:4/20/2014)... crop residue to make ethanol and other biofuels reduces ... gasoline, according to a study published today in the ... by a University of Nebraska-Lincoln team of researchers cast ... meet federal mandates to ramp up ethanol production and ... stalks, leaves and cobs in cornfields after harvest -- ...
(Date:4/18/2014)... while feeding a world population predicted to reach ... approach to conservation that considers human-altered landscapes such ... and the natural habitat that supports it might ... where at least three-quarters of the land surface ... is vulnerable to human-caused impacts such as climate ...
Breaking Biology News(10 mins):Cancer stem cells linked to drug resistance 2Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4
(Date:4/18/2014)... LEXINGTON, Ky. (April 21, 2014) -- A group ... of Medicine and the Sanders-Brown Center on Aging ... on depression and neuropsychological function in Parkinson,s disease ... Psychiatry Research , the study, which assessed cognitive ... found that the dopamine replacement therapy commonly used ...
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/17/2014)... in non-cancerous prostate tissue may have nearly twice the ... no inflammation, according to results of a new study ... Center. , The link between persistent inflammation and cancer ... cancer those with a Gleason score between 7 ... aggressive and rapidly growing prostate cancers. , "What we,ve ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2
Other Contents